Literature DB >> 24709965

Bladder cancer: better clinical outcomes with BCG Connaught than Tice.

Sarah Payton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24709965     DOI： 10.1038/nrurol.2014.76

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy.

Authors:  Cyrill A Rentsch; Frédéric D Birkhäuser; Claire Biot; Joël R Gsponer; Aurélie Bisiaux; Christian Wetterauer; Micheline Lagranderie; Gilles Marchal; Mickael Orgeur; Christiane Bouchier; Alexander Bachmann; Molly A Ingersoll; Roland Brosch; Matthew L Albert; George N Thalmann
Journal:  Eur Urol       Date:  2014-03-12       Impact factor: 20.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.